Nature Cancer最新收录文章列表-丁香通

大类医学

小类肿瘤学

EISSN2662-1347

最新文献

M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors

PMID: 417033222026-04

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results

PMID: 418515062026-03-18

Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study

PMID: 418078172026-03-10

Diagnostic accuracy, fairness and clinical implementation of AI for breast cancer screening: results of multicenter retrospective and prospective technical feasibility studies

PMID: 418078182026-03-10

Impact of using artificial intelligence as a second reader in breast screening including arbitration

PMID: 418078162026-03-10

The automated computational workflow QUICHE reveals structural definitions of antitumor responses in triple-negative breast cancer

PMID: 417088932026-03

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma

PMID: 418821792026-03

The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations

PMID: 417356402026-02-24

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

PMID: 417148242026-02-19

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

PMID: 416119982026-01-29

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma

PMID: 415140532026-01-09

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial

PMID: 415140542026-01-09

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

PMID: 415075392026-01-08

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

PMID: 414920942026-01-05

De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function

PMID: 414920912026-01-05

TGFβ induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis

PMID: 414920902026-01-05

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial

PMID: 414920932026-01-05

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

PMID: 415882402026-01

Cellular neighborhoods in cancer

PMID: 415457132026-01

CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency

PMID: 414955262026-01